Fang, Yao‐Ching
48  results:
Search for persons X
?
1

Molecular Biomarkers Affecting Moyamoya Disease:

, In: Advances and Technical Standards in Neurosurgery,
Tu, Yong-Kwang ; Fang, Yao-Ching - p. 1-18 , 2024
 
?
2

Endothelial Dysfunction in Neurodegenerative Diseases:

Fang, Yao-Ching ; Hsieh, Yi-Chen ; Hu, Chaur-Jong.
International Journal of Molecular Sciences.  24 (2023)  3 - p. 2909 , 2023
 
?
6

HDACi protects against vascular cognitive impairment from C..:

Fang, Yao‐Ching ; Hsieh, Jia‐Yu ; Vidyanti, Amelia Nur...
Journal of Cellular and Molecular Medicine.  25 (2021)  15 - p. 7418-7425 , 2021
 
?
7

Pathological Circulating Factors in Moyamoya Disease:

Fang, Yao-Ching ; Wei, Ling-Fei ; Hu, Chaur-Jong.
International Journal of Molecular Sciences.  22 (2021)  4 - p. 1696 , 2021
 
?
8

Role of HMGB1 in an Animal Model of Vascular Cognitive Impa..:

Vidyanti, Amelia Nur ; Hsieh, Jia-Yu ; Lin, Kun-Ju...
International Journal of Molecular Sciences.  21 (2020)  6 - p. 2176 , 2020
 
?
9

HDAC inhibitor protects chronic cerebral hypoperfusion and ..:

Fang, Yao‐Ching ; Chan, Lung ; Liou, Jing‐Ping...
Journal of Cellular and Molecular Medicine.  24 (2020)  12 - p. 6966-6977 , 2020
 
?
10

Protective effects of 10,11-dihydro-5H-dibenzo[b,f]azepine ..:

Kaur, Navdeep ; Fang, Yao-Ching ; Lee, Hsueh-Yun...
European Journal of Medicinal Chemistry.  187 (2020)  - p. 111915 , 2020
 
?
 
?
12

Potent inhibition of human neutrophil activations by bracte..:

Wu, Yang-Chang ; Sureshbabu, Munisamy ; Fang, Yao-Ching...
Toxicology and Applied Pharmacology.  266 (2013)  3 - p. 399-407 , 2013
 
?
13

YC-1 potentiates cAMP-induced CREB activation and nitric ox..:

Hwang, Tsong-Long ; Tang, Ming-Chi ; Kuo, Liang-Mou...
Toxicology and Applied Pharmacology.  260 (2012)  2 - p. 193-200 , 2012
 
?
14

Induction of Prostacyclin/PGI2 Synthase Expression After Ce..:

Fang, Yao-Ching ; Wu, Jui-Sheng ; Chen, Jean-Ju...
Journal of Cerebral Blood Flow & Metabolism.  26 (2005)  4 - p. 491-501 , 2005
 
1-15